Abstract: A system for moving cargo includes an in-vehicle conveyor system mounted in a vehicle cargo space, the in-vehicle conveyor system comprising one or more rails. The rails may be mounted to walls, floor, or ceiling of the vehicle cargo space. The system also includes one or more cargo storage units attached to the in-vehicle conveyor system. Each of the one or more cargo storage units is secured to the rails such that the one or more cargo storage units are raised with respect to a floor of the vehicle cargo space and define a circuit as based on a travel path of the one or more cargo storage units. Upon instruction, the cargo storage units are movable along the circuit to move a specified cargo storage unit to a predetermined location.

Abstract: A pharmaceutical composition and formulations comprise preventative, prophylactic or therapeutic amounts of an oligo(s) anti-sense to a specific gene(s) or its corresponding mRNA(s), and a glucocorticoid and/or non-glucocorticoid steroid or a ubiquinone or their salts. The agents, composition and formulations are used for treatment of ailments associated with impaired respiration, bronchoconstriction, lung allergy(ies) or inflammation, and abnormal levels of adenosine, adenosine receptors, sensitivity to adenosine, lung surfactant and ubiquinone, such as pulmonary fibrosis, vasoconstriction, inflammation, allergies, allergic rhinitis, asthma, impeded respiration, lung pain, cystic fibrosis, bronchoconstriction, COPD, RDS, ARDS, cancer, and others. The present treatment is effectively administered by itself for conditions without known therapies, as a substitute for therapies exhibiting undesirable side effects, or in combination with other treatments, e.g.